1. Home
  2. IAS vs AVDL Comparison

IAS vs AVDL Comparison

Compare IAS & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IAS
  • AVDL
  • Stock Information
  • Founded
  • IAS 2009
  • AVDL 2015
  • Country
  • IAS United States
  • AVDL Ireland
  • Employees
  • IAS N/A
  • AVDL N/A
  • Industry
  • IAS Computer Software: Programming Data Processing
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • IAS Technology
  • AVDL Health Care
  • Exchange
  • IAS Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • IAS 1.7B
  • AVDL 1.8B
  • IPO Year
  • IAS 2021
  • AVDL 1996
  • Fundamental
  • Price
  • IAS $10.25
  • AVDL $18.70
  • Analyst Decision
  • IAS Buy
  • AVDL Buy
  • Analyst Count
  • IAS 11
  • AVDL 9
  • Target Price
  • IAS $13.57
  • AVDL $18.06
  • AVG Volume (30 Days)
  • IAS 1.4M
  • AVDL 4.8M
  • Earning Date
  • IAS 11-04-2025
  • AVDL 11-04-2025
  • Dividend Yield
  • IAS N/A
  • AVDL N/A
  • EPS Growth
  • IAS 42.72
  • AVDL N/A
  • EPS
  • IAS 0.28
  • AVDL N/A
  • Revenue
  • IAS $590,666,000.00
  • AVDL $248,517,000.00
  • Revenue This Year
  • IAS $14.72
  • AVDL $64.21
  • Revenue Next Year
  • IAS $11.34
  • AVDL $30.80
  • P/E Ratio
  • IAS $36.70
  • AVDL N/A
  • Revenue Growth
  • IAS 15.51
  • AVDL 79.88
  • 52 Week Low
  • IAS $6.26
  • AVDL $6.38
  • 52 Week High
  • IAS $12.86
  • AVDL $19.06
  • Technical
  • Relative Strength Index (RSI)
  • IAS 69.49
  • AVDL 73.80
  • Support Level
  • IAS $10.21
  • AVDL $18.74
  • Resistance Level
  • IAS $10.23
  • AVDL $19.00
  • Average True Range (ATR)
  • IAS 0.02
  • AVDL 0.35
  • MACD
  • IAS -0.04
  • AVDL 0.00
  • Stochastic Oscillator
  • IAS 76.92
  • AVDL 89.36

About IAS Integral Ad Science Holding Corp.

Integral Ad Science Holding Corp is a digital advertising verification company. The cloud-based technology platform of the company delivers independent measurement and verification of digital advertising across all devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video. Geographically, the company derives a majority of its revenue from the Americas region.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: